Tracy Lisi

Tracy Lisi is an accomplished professional with extensive experience in clinical operations and project management within the pharmaceutical industry. Currently serving as the Director of Global Clinical Operations at Daiichi Sankyo US, Tracy leads the Late Phase Oncology Program, managing all aspects of project lifecycle, including timelines, deliverables, and budgets. Previous roles include Clinical Operations Asset Lead at Spark Therapeutics, overseeing hematology programs, and Director of Study Management at Pfizer, where responsibilities encompassed risk mitigation and resource allocation for clinical trials. With a strong foundation in clinical study management, Tracy's background spans various organizations, including Parexel, ExecuPharm, and Merck, complemented by a Master's degree in Health Care Administration from Saint Joseph's University and additional qualifications in Speech-Language Pathology.